July 24, 2007 – The new senior vice president of MEDRAD Inc.’s Magnetic Resonance Strategic Business Unit is Joseph Havrilla. He is responsible for overseeing the development and marketing of MEDRAD's full line of MR-compatible accessories and patient care products. Havrilla will also continue in his role as senior vice president of Corporate Innovation.
Havrilla joined MEDRAD in 1983 as a research engineer and holds over two dozen patents. Throughout the years he and his team have brought some of MEDRAD’s most innovative products to market, including MCT/MCT , the Front Load Syringe, Mark V, Envision, Stellant, prefilled cartridges, Spectris and Spectris Solaris ProVis and the 9500 monitor line.
"We owe much of MEDRAD's worldwide reputation for innovation to the efforts of Joe and his team," said MEDRAD President and CEO John P. Friel. "He brings the historical perspective to his new role, coupled with the depth of experience to enable us to meet our aggressive product development goals."
For more information: www.medrad.com
July 25, 2024 
